Targets and effectors of the cellular response to aurora kinase inhibitor MK-0457 (VX-680) in imatinib sensitive and resistant chronic myelogenous leukemia-Reference-Cited by-同舟云学术

Targets and effectors of the cellular response to aurora kinase inhibitor MK-0457 (VX-680) in imatinib sensitive and resistant chronic myelogenous leukemia

Published:2010-03 Issue:5 Volume:79 Page:688-697
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Donato Nicholas J.,Fang Dexing,Sun Hanshi,Giannola Diane,Peterson Luke F.,Talpaz Moshe

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference39 articles.

1. Translation of the Philadelphia chromosome into therapy for CML;Druker;Blood,2008

2. Molecular biology of bcr-abl1-positive chronic myeloid leukemia;Quintás-Cardama;Blood,2009

3. First-line management of CML: a state of the art review;Hochhaus;J Natl Compr Canc Netw,2008

4. New Bcr-Abl inhibitors in chronic myeloid leukemia: keeping resistance in check;O’Hare;Expert Opin Investig Drugs,2008

5. Flying under the radar: the new wave of BCR-ABL inhibitors;Quintás-Cardama;Nat Rev Drug Discov,2007

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Status, Synthesis and Clinical Application of Recently Marketed and Clinical BCR-ABL Inhibitors;Current Medicinal Chemistry;2021-10-12

2. Effect of Dasatinib on Genes Related to Mitotic Catastrophe Pathway in Chronic Myeloid Leukemia Cells;Anti-Cancer Agents in Medicinal Chemistry;2021-07-26

3. Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy;Molecular Cancer;2021-01-15

4. Identification of Target Associations for Polypharmacology from Analysis of Crystallographic Ligands of the Protein Data Bank;Journal of Chemical Information and Modeling;2019-12-04

5. Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma;Haematologica;2019-04-04